Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 131-140 of 151 for Amyloidosis

Edit search filters
  1. A Non-interventional Cohort Safety Study Of Patients With HATTR-PN

    Rochester, MN

  2. A Study to Evaluate the Prevalence of Transthyretin Cardiac Amyloidosis in Heart Failure Patients with Preserved Ejection Fraction in Southeastern Minnesota

    Rochester, MN

  3. Development Of A Normal Hematologic Resource For The Aging Mechanisms In Myeloma, Amyloid, And Dysproteinemia Diseases

    Rochester, MN

  4. Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis

    Rochester, MN

  5. A Study to Understand the Clinical Characteristics and to Identify Gene(s) and/or Protein(s) causing Amyloid Myopathy

    Rochester, MN

  6. Human Heart Transplantation Stress Granule Mediated Cellular Preservation

    Jacksonville, FL

  7. A Study To Assess Financial Burden And Its Impact On Quality Of Life In Patients With Plasma Cell Disorders

    Rochester, MN

  8. Appointment Companion Tool

    Rochester, MN

  9. ATTR Expanded Access Program (EAP) By Ionis

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. A Non-Interventional Study To Monitor The Survival Status Of Patients That Discontinued From ISIS 420915-CS2 Or ISIS 420915-CS3

    Rochester, MN

.

Mayo Clinic Footer